Cargando…

Assessment of the contribution of APOE gene variants to metabolic phenotypes associated with familial longevity at middle age

Offspring of long-lived families are characterized by beneficial metabolic phenotypes in glucose and lipid metabolism and low 25-hydroxyvitamin D. Although the genetic basis for human longevity remains largely unclear, the contribution of variation at the APOE locus has been repeatedly demonstrated....

Descripción completa

Detalles Bibliográficos
Autores principales: Noordam, Raymond, Oudt, Charlotte H., Deelen, Joris, Slagboom, P. Eline, Beekman, Marian, van Heemst, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032696/
https://www.ncbi.nlm.nih.gov/pubmed/27540764
http://dx.doi.org/10.18632/aging.101017
_version_ 1782455044253155328
author Noordam, Raymond
Oudt, Charlotte H.
Deelen, Joris
Slagboom, P. Eline
Beekman, Marian
van Heemst, Diana
author_facet Noordam, Raymond
Oudt, Charlotte H.
Deelen, Joris
Slagboom, P. Eline
Beekman, Marian
van Heemst, Diana
author_sort Noordam, Raymond
collection PubMed
description Offspring of long-lived families are characterized by beneficial metabolic phenotypes in glucose and lipid metabolism and low 25-hydroxyvitamin D. Although the genetic basis for human longevity remains largely unclear, the contribution of variation at the APOE locus has been repeatedly demonstrated. We aimed to assess whether ApoE isoforms mark the familial longevity status in middle age and subsequently to test to what extend this association is mediated by the metabolic characteristics marking this status. From the Leiden Longevity Study (LLS), we included offspring from nonagenarian siblings and partners as controls. Using the metabolic phenotypes of familial longevity as mediators, we investigated how APOE gene variants associated with LLS offspring/control status (in 1,515 LLS offspring and 715 controls). Within the LLS (mean age = 59.2 years), ApoE ε4 was not associated with a lower likelihood of being an LLS offspring, whereas ApoE ɛ2 was significantly associated with a higher likelihood of being an LLS offspring (odds ratio = 1.43), but this difference was not mediated (p-values>0.05) by any of the investigated metabolic phenotypes (e.g., diabetes and glucose). Therefore, variation at the APOE locus may not influence familial longevity status in middle age significantly through any of the metabolic mechanisms investigated.
format Online
Article
Text
id pubmed-5032696
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-50326962016-09-29 Assessment of the contribution of APOE gene variants to metabolic phenotypes associated with familial longevity at middle age Noordam, Raymond Oudt, Charlotte H. Deelen, Joris Slagboom, P. Eline Beekman, Marian van Heemst, Diana Aging (Albany NY) Research Paper Offspring of long-lived families are characterized by beneficial metabolic phenotypes in glucose and lipid metabolism and low 25-hydroxyvitamin D. Although the genetic basis for human longevity remains largely unclear, the contribution of variation at the APOE locus has been repeatedly demonstrated. We aimed to assess whether ApoE isoforms mark the familial longevity status in middle age and subsequently to test to what extend this association is mediated by the metabolic characteristics marking this status. From the Leiden Longevity Study (LLS), we included offspring from nonagenarian siblings and partners as controls. Using the metabolic phenotypes of familial longevity as mediators, we investigated how APOE gene variants associated with LLS offspring/control status (in 1,515 LLS offspring and 715 controls). Within the LLS (mean age = 59.2 years), ApoE ε4 was not associated with a lower likelihood of being an LLS offspring, whereas ApoE ɛ2 was significantly associated with a higher likelihood of being an LLS offspring (odds ratio = 1.43), but this difference was not mediated (p-values>0.05) by any of the investigated metabolic phenotypes (e.g., diabetes and glucose). Therefore, variation at the APOE locus may not influence familial longevity status in middle age significantly through any of the metabolic mechanisms investigated. Impact Journals LLC 2016-08-18 /pmc/articles/PMC5032696/ /pubmed/27540764 http://dx.doi.org/10.18632/aging.101017 Text en Copyright: © 2016 Noordam et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Noordam, Raymond
Oudt, Charlotte H.
Deelen, Joris
Slagboom, P. Eline
Beekman, Marian
van Heemst, Diana
Assessment of the contribution of APOE gene variants to metabolic phenotypes associated with familial longevity at middle age
title Assessment of the contribution of APOE gene variants to metabolic phenotypes associated with familial longevity at middle age
title_full Assessment of the contribution of APOE gene variants to metabolic phenotypes associated with familial longevity at middle age
title_fullStr Assessment of the contribution of APOE gene variants to metabolic phenotypes associated with familial longevity at middle age
title_full_unstemmed Assessment of the contribution of APOE gene variants to metabolic phenotypes associated with familial longevity at middle age
title_short Assessment of the contribution of APOE gene variants to metabolic phenotypes associated with familial longevity at middle age
title_sort assessment of the contribution of apoe gene variants to metabolic phenotypes associated with familial longevity at middle age
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032696/
https://www.ncbi.nlm.nih.gov/pubmed/27540764
http://dx.doi.org/10.18632/aging.101017
work_keys_str_mv AT noordamraymond assessmentofthecontributionofapoegenevariantstometabolicphenotypesassociatedwithfamiliallongevityatmiddleage
AT oudtcharlotteh assessmentofthecontributionofapoegenevariantstometabolicphenotypesassociatedwithfamiliallongevityatmiddleage
AT deelenjoris assessmentofthecontributionofapoegenevariantstometabolicphenotypesassociatedwithfamiliallongevityatmiddleage
AT slagboompeline assessmentofthecontributionofapoegenevariantstometabolicphenotypesassociatedwithfamiliallongevityatmiddleage
AT beekmanmarian assessmentofthecontributionofapoegenevariantstometabolicphenotypesassociatedwithfamiliallongevityatmiddleage
AT vanheemstdiana assessmentofthecontributionofapoegenevariantstometabolicphenotypesassociatedwithfamiliallongevityatmiddleage